Pulkki, Kari

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 2,498

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

Nordestgaard, B. G., Langsted, A., Mora, S., Kolovou, G., Baum, H., Bruckert, E., Watts, G. F., Sypniewska, G., Wiklund, O., Borén, J., et al. (2016) · European Heart Journal

Lipoproteins and Cardiovascular HealthClinical Laboratory Practices and Quality Control

Cited by 847

Apoptosis in human acute myocardial infarction.

Saraste, A., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M., & Voipio-Pulkki, L.-M. (1997) · Circulation

Cardiac Ischemia and ReperfusionCell death mechanisms and regulation

Cited by 825

Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial

Bjermo, H., Iggman, D., Kullberg, J., Dahlman, I., Johansson, L., Persson, L., Berglund, J., Pulkki, K., Basu, S., Uusitupa, M., et al. (2012) · The American Journal of Clinical Nutrition

Fatty Acid Research and HealthDiet, Metabolism, and Disease

Cited by 490

Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex

Katrukha, A. G., Bereznikova, A. V., Esakova, T. V., Pettersson, K., Lövgren, T., Severina, M. E., Pulkki, K., Vuopio-Pulkki, L.-M., & Gusev, N. B. (1997) · Clinical Chemistry

Acute Myocardial Infarction ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 266

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Langlois, M. R., Chapman, M. J., Cobbaert, C., Mora, S., Remaley, A. T., Ros, E., Watts, G. F., Borén, J., Baum, H., Bruckert, E., et al. (2018) · Clinical Chemistry

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 260

Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

Nordestgaard, B. G., Langlois, M. R., Langsted, A., Chapman, M. J., Aakre, K. M., Baum, H., Borén, J., Bruckert, E., Catapano, A., Cobbaert, C., et al. (2020) · Atherosclerosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 246

Degradation of cardiac troponin I: implication for reliable immunodetection

Katrukha, A. G., Bereznikova, A. V., Filatov, V. L., Esakova, T. V., Kolosova, O. V., Pettersson, K., Lövgren, T., Bulargina, T. V., Trifonov, I. R., Gratsiansky, N. A., et al. (1998) · Clinical Chemistry

Acute Myocardial Infarction ResearchClinical Laboratory Practices and Quality Control

Cited by 232

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

Langlois, M. R., Nordestgaard, B. G., Langsted, A., Chapman, M. J., Aakre, K. M., Baum, H., Borén, J., Bruckert, E., Catapano, A., Cobbaert, C., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM)

Lipoproteins and Cardiovascular HealthClinical Laboratory Practices and Quality Control

Cited by 211

Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group

Langlois, M. R., Descamps, O. S., van der Laarse, A., Weykamp, C., Baum, H., Pulkki, K., von Eckardstein, A., De Bacquer, D., Borén, J., Wiklund, O., et al. (2014) · Atherosclerosis

Clinical Laboratory Practices and Quality ControlLipoproteins and Cardiovascular Health

Cited by 72

Intranasally administered insulin intended for prevention of type 1 diabetes—a safety study in healthy adults

Kupila, A., Sipilä, J., Keskinen, P., Simell, T., Knip, M., Pulkki, K., & Simell, O. (2003) · Diabetes/Metabolism Research and Reviews

Diabetes and associated disordersDiabetes Management and Research

Cited by 64

Adenosine in Myocardial Protection given through three windows of opportunity. An experimental study with pigs.

Vähäsilta, T., Virtanen, J., Saraste, A., Luotolahti, M., Pulkki, K., Valtonen, M., Voipio-Pulkki, L.-M., & Savunen, T. (2001) · Scandinavian Cardiovascular Journal

Cardiac Ischemia and ReperfusionCardiac and Coronary Surgery Techniques

Cited by 9